glp-1 and appetite Medications – Community Education GLP-1 for Weight Loss and

Safety and Metabolism of AOD9604, a Novel Nutraceutical Ingredient for Improved Metabolic Health Journal of Endocrinology & Metabolism, Volume 4, Number 3, June 2014, Pages 64-77

Food and Drug Administration (FDA) to treat type 2 diabetes mellitus and lower the risk of heart attack or stroke in people with type 2 diabetes and cardiovascular disease

Stop and Seek Help If Severe allergic reaction (rash, swelling, difficulty breathing) Persistent severe nausea or vomiting not improving with dose reduction Signs of pancreatitis (severe abdominal pain radiating to back) Planned pregnancy or positive pregnancy test Inability to maintain adequate nutrition despite dose adjustments Any concerning symptoms your healthcare provider advises stopping for Always consult your healthcare provider before stopping or modifying your dose

Patients should consult with a registered dietitian or healthcare provider to ensure their protein shake selection aligns with individual metabolic needs, food sensitivities, and treatment goals

In case of a deficiency of glutathione, administration of glutathione as a supplement could offer support